Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate-Reference-Cited by-同舟云学术

Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate

Published:2020-09 Issue:3 Volume:1 Page:100077
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Arcila Maria E.,Yang Soo-Ryum,Momeni Amir,Mata Douglas A.,Salazar Paulo,Chan Roger,Elezovic Daniela,Benayed Ryma,Zehir Ahmet,Buonocore Darren J.,Rekhtman Natasha,Lin Oscar,Ladanyi Marc,Nafa Khedoudja

Funder

Comprehensive Cancer Center

National Institutes of Health

Publisher

Elsevier BV

Reference47 articles.

1. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

2. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

3. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann Oncol,2018

4. Pan-Asian adapted clinical practice guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS;Wu;Ann Oncol,2019

5. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study;Frontiers in Oncology;2024-07-09

2. Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters;Scientific Reports;2024-06-06

3. Microfluidics‐based EGFR mutation detection and its implication in the resource‐limited clinical setting;International Journal of Experimental Pathology;2024-05-08

4. Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel Sequencing;Cancers;2024-02-15

5. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla ^TM platform: a real-world two-center experience in Greece;Expert Review of Molecular Diagnostics;2024-01-11